Alumis Inc. (ALMS) Insider Trading
Directors, officers and holders of more than 10% of ALMS report their trades in its stock on SEC Form 4, within two business days. Each row below is one Form 4 transaction line. The one-letter code says what kind of transaction it was: only P (purchase) and S (sale) are open-market or private trades; awards, option exercises, tax withholding and gifts carry other codes.
Recent Form 4 transactions
The 50 most recent of 135 transactions on file: 6 with code P, 9 with code S and 35 with other codes.
| Date | Insider | Title | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 8, 2026 | AKKARAJU SRINIVAS | Director | S Sale | 48,065 | $10.55 | $507,009 |
| Sep 8, 2026 | AKKARAJU SRINIVAS | Director | P Purchase | 273,291 | $10.63 | $2,904,291 |
| Sep 8, 2026 | AKKARAJU SRINIVAS | Director | P Purchase | 273,290 | $10.63 | $2,904,280 |
| Sep 8, 2026 | AKKARAJU SRINIVAS | Director | S Sale | 48,066 | $10.55 | $507,019 |
| Sep 4, 2026 | AKKARAJU SRINIVAS | Director | P Purchase | 220,070 | $11.17 | $2,458,842 |
| Sep 4, 2026 | AKKARAJU SRINIVAS | Director | P Purchase | 220,070 | $11.17 | $2,458,842 |
| Aug 3, 2026 | Schroer John R. | Chief Financial Officer | S Sale | 3,282 | $26.37 | $86,546 |
| Aug 3, 2026 | Pangali Sanam | Chief Legal Officer | S Sale | 1,364 | $26.37 | $35,969 |
| Aug 3, 2026 | Goldstein David M | Chief Scientific Officer | S Sale | 2,596 | $26.37 | $68,457 |
| Aug 3, 2026 | Bradley Mark Christopher | Chief Development Officer | S Sale | 2,572 | $26.37 | $67,824 |
| Aug 3, 2026 | Drappa Jorn | Chief Medical Officer | S Sale | 2,447 | $26.37 | $64,527 |
| Aug 3, 2026 | Hardiman Roy C. | Chief Business & Strategy Ofcr | S Sale | 2,692 | $26.37 | $70,988 |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | M Exercise | 5,000 | $5.06 | $25,300 |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | S Sale | 5,000 | $28.00 | $140,000 |
| Jul 6, 2026 | Pangali Sanam | Chief Legal Officer | M Exercise | 5,000 | Not measured | Not measured |
| Jun 30, 2026 | Machado Patrick | Director | A Award | 15,528 | Not measured | Not measured |
| Jun 30, 2026 | Srivastava Sapna | Director | A Award | 3,553 | Not measured | Not measured |
| Jun 30, 2026 | TETRAULT LYNN A. | Director | A Award | 3,553 | Not measured | Not measured |
| Jun 30, 2026 | Yao Zhengbin | Director | A Award | 3,553 | Not measured | Not measured |
| Jun 30, 2026 | Machado Patrick | Director | A Award | 3,553 | Not measured | Not measured |
| Jun 30, 2026 | AKKARAJU SRINIVAS | Director | A Award | 15,528 | Not measured | Not measured |
| Jun 30, 2026 | Srivastava Sapna | Director | A Award | 15,528 | Not measured | Not measured |
| Jun 30, 2026 | Yao Zhengbin | Director | A Award | 15,528 | Not measured | Not measured |
| Jun 30, 2026 | TETRAULT LYNN A. | Director | A Award | 15,528 | Not measured | Not measured |
| Jun 30, 2026 | AKKARAJU SRINIVAS | Director | A Award | 3,553 | Not measured | Not measured |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | M Exercise | 11,317 | Not measured | Not measured |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | M Exercise | 11,317 | $8.84 | $100,042 |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | M Exercise | 15,535 | $5.06 | $78,607 |
| May 22, 2026 | Drappa Jorn | Chief Medical Officer | M Exercise | 15,535 | Not measured | Not measured |
| Apr 1, 2026 | Tananbaum James B. | Director | J Other | 1,176,470 | Not measured | Not measured |
| Apr 1, 2026 | Tananbaum James B. | Director | J Other | 680,486 | Not measured | Not measured |
| Apr 1, 2026 | Tananbaum James B. | Director | J Other | 1,123,337 | Not measured | Not measured |
| Apr 1, 2026 | Tananbaum James B. | Director | J Other | 1,123,337 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | J Other | 680,486 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | J Other | 1,123,337 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | J Other | 1,123,337 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Capital Management VI LLC | 10% Owner | J Other | 1,176,470 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | J Other | 680,486 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | J Other | 1,123,337 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | J Other | 1,123,337 | Not measured | Not measured |
| Apr 1, 2026 | Foresite Labs, LLC | 10% Owner | J Other | 1,176,470 | Not measured | Not measured |
| Jan 26, 2026 | Drappa Jorn | Chief Medical Officer | A Award | 221,450 | Not measured | Not measured |
| Jan 26, 2026 | Schroer John R. | Chief Financial Officer | A Award | 202,225 | Not measured | Not measured |
| Jan 26, 2026 | Pangali Sanam | Chief Legal Officer | A Award | 186,200 | Not measured | Not measured |
| Jan 26, 2026 | Bradley Mark Christopher | Chief Development Officer | A Award | 190,225 | Not measured | Not measured |
| Jan 26, 2026 | Goldstein David M | Chief Scientific Officer | A Award | 216,675 | Not measured | Not measured |
| Jan 26, 2026 | Babler Martin | President, CEO and Chairman | A Award | 745,875 | Not measured | Not measured |
| Jan 26, 2026 | Hardiman Roy C. | Chief Business & Strategy Ofcr | A Award | 190,875 | Not measured | Not measured |
| Jan 9, 2026 | AKKARAJU SRINIVAS | Director | P Purchase | 588,235 | $17.00 | $9,999,995 |
| Jan 8, 2026 | Foresite Capital Management VI LLC | 10% Owner | P Purchase | 117,647 | $17.00 | $1,999,999 |
The full Form 4 history is on the ALMS company page (Insider Trades card, View all).
Questions about this data
Which insider transactions are open-market trades?
Code P (open market or private purchase) and code S (open market or private sale). Code F is shares withheld to pay tax on vesting stock, A is an award from the company, M and X are option exercises and G is a gift. None of those is the insider choosing to buy or sell in the market.
How quickly are insider trades reported?
A Form 4 is due before the end of the second business day after the trade. The date shown is the transaction date from the form.
Who has to file Form 4?
Officers, directors and beneficial owners of more than 10% of a class of the company’s registered equity, under Section 16 of the Securities Exchange Act.
Look up any code in the Form 4 transaction code reference, or read Form 4 codes explained.